Isodiol International Inc. establishes operations in Mexico and will commence shipment of Cannabinol products

VANCOUVER, June 21, 2017

With the Monday June 19^th, 2017 announcement by Mexican President Enrique Pena Nieto, Mexico has now officially legalized Medical Marijuana.  The bill legalizes the buying, selling, importing and exporting of cannabis products with less than 1% THC.  Cannabis related products are now available for medical use and gives people in Mexico access to products containing THC for the first time.

CEO of Isodiol International Inc. Marcos Agramont stated, "Anticipating the medical cannabis legalization in Mexico, we have spent the last few months investing in infrastructure to expand our distribution into that market.  Through our online sales platform, we will immediately be able to commence distribution and build a footprint within Mexico. We will also continue to work through the approval process with Comision Federal para la Proteccion contra Riesgos Sanitarios ("COFEPRIS") for our manufacturing permit which will allow us to produce in Mexico.  This is a very important step for us, as we continue to build out a fully vertically integrated operation, which is being replicated domestically and in every market we enter."

The company will provide additional information in the coming weeks.

About Isodiol International Inc.

Isodiol International, Inc. is a market leader in pharmaceutical grade cannabis compounds and a leading manufacturer and developer of consumer products. Isodiol's nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology utilized in the highest quality consumable and topical skin care products. 

Isodiol's growth strategy includes the development and production of over-the-counter and pharmaceutical products, continued expansion of its current sales channels, engaging in joint ventures and acquisitions to expand its portfolio of brands. Isodiol and its subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.